These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2412005)

  • 41. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive medications.
    Slagle MA
    South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
    [No Abstract]   [Full Text] [Related]  

  • 43. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 45. Vasodilation and Antihypertensive Activities of Swietenia macrophylla (Mahogany) Seed Extract.
    Ch'ng YS; Loh YC; Tan CS; Ahmad M; Asmawi MZ; Wan Omar WM; Yam MF
    J Med Food; 2018 Mar; 21(3):289-301. PubMed ID: 29420109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart.
    Hof RP; Salzmann R; Siegl H
    Am J Cardiol; 1987 Jan; 59(3):30B-36B. PubMed ID: 2949586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Position of calcium antagonists in antihypertensive therapy.
    Bühler FR; Bolli P; Erne P; Kiowski W; Müller FB; Hulthén UL; Ji BH
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S21-7. PubMed ID: 2412007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic and antihypertensive treatment responses with calcium antagonists.
    Bolli P; Kiowski W; Erne P; Hulthén LU; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S126-30. PubMed ID: 2409361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological rationale for antihypertensive drug treatment.
    Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemistry of calcium antagonists.
    Meyer H; Bossert F; Wehinger E; Towart R; Bellemann P
    Hypertension; 1983; 5(4 Pt 2):II2-7. PubMed ID: 6345372
    [No Abstract]   [Full Text] [Related]  

  • 54. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Psychoneurotic dysfunctions as side effect of antihypertensive agents].
    Togashi H; Saito H
    Nihon Rinsho; 1992 May; 50 Suppl():93-8. PubMed ID: 1355143
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative cardiovascular effects of drugs used for hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    Drugs; 1990; 39 Suppl 1():32-8. PubMed ID: 1968375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?
    Jacob S; Rett K; Henriksen EJ
    Am J Hypertens; 1998 Oct; 11(10):1258-65. PubMed ID: 9799045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.